Waldemar Baldoquín Rodríguez

Dr. Waldemar Baldoquín Rodríguez

Institute of Tropical Medicine Pedro Kouri, Havana, La Habana, Cuba
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2021 in Insects
Verified
Journal Article
Open access
PDF file
RARené Gato Armas
René Gato Armas
ZMZulema Menéndez
Zulema Menéndez
EPEnrique Prieto
Enrique Prieto
RARafael Argilés
Rafael Argilés
MRMisladys Rodríguez
Misladys Rodríguez
JBJérémy Bouyer
Jérémy Bouyer
Dengue virus infections are a serious public health problem worldwide. Aedes aegypti is the primary vector of dengue in Cuba. As there is no vaccine or specific treatment, the control efforts are directed to the reduction of mosquito populations. The indiscriminate use of insecticides can lead to adverse effects on ecosystems, including human health. The sterile insect technique is a species-specific and environment-friendly method of insect population control based on the release of large numbers of sterile insects, ideally males only. The success of this technique for the sustainable management of agricultural pests has encouraged its evaluation for the population suppression of mosquito vector species. Here, we describe an open field trial to evaluate the effect of the release of irradiated male Ae. aegypti on a wild population. The pilot trial was carried out in a suburb of Havana and compared the mosquito population density before and after the intervention, in both untreated control and release areas. The wild population was monitored by an ovitrap network, recording frequency and density of eggs as well as their hatch rate. A significant amount of sterility was induced in the field population of the release area, as compared with the untreated control area. The ovitrap index and the mean number of eggs/trap declined dramatically after 12 and 5 weeks of releases, respectively. For the last 3 weeks, no eggs were collected in the treatment area, clearly indicating a significant suppression of the wild target population. We conclude that the sterile males released competed successfully and induced enough sterility to suppress the local Ae. aegypti population.

31 December 2022 in The Lancet Regional Health - Americas
Verified
Journal Article
Open access
MTMaría Eugenia Toledo-Romaní
María Eugenia Toledo-Romaní
MGMayra García-Carmenate
Mayra García-Carmenate
CVCarmen Valenzuela-Silva
Carmen Valenzuela-Silva
WRWaldemar Baldoquín Rodríguez
Waldemar Baldoquín Rodríguez
MMMarisel Martínez-Pérez
Marisel Martínez-Pérez
VVVicente Verez-Bencomo
Vicente Verez-Bencomo
SOBERANA-02 is a COVID-19 conjugate vaccine (recombinant RBD conjugated to tetanus toxoid). Phases 1/2 clinical trials demonstrated high immunogenicity, promoting neutralising IgG and specific T-cell response. A third heterologous dose of SOBERANA-Plus (RBD-dimer) further increased neutralising antibodies. The aim of this study is to evaluate the safety and efficacy of two immunisation regimes: two doses of SOBERANA-02 and a heterologous three-dose combination with SOBERANA-Plus added to it. From March 8th to June 24th, 2021 we conducted in Havana, Cuba a multicentre randomised, double-blind, placebo-controlled, phase-3 trial evaluating a two doses SOBERANA-02 scheme and a heterologous scheme with one dose SOBERANA-Plus added to it (RPCEC00000354). Participants 19-80 years were randomly assigned to receiving 28 days apart either the two or three dose scheme or placebo. The main endpoint was vaccine efficacy in preventing the occurrence of RT-PCR confirmed symptomatic COVID-19 at least 14 days after the second or third dose in the per-protocol population. We also assessed efficacy against severe disease and, in all participants receiving at least one vaccine/placebo dose, safety for 28 days after each dose. We included 44,031 participants (52.0% female, 48.0% male; median age 50 years, range 19-80 years; 7.0% black, 24.0% mixed-race, 59.0% white) in a context of initial Beta VOC predominance, with this variant being partially replaced by Delta near the trial's end. Vaccine efficacy in the heterologous combination was 92.0% (95%CI 80.4-96.7) against symptomatic disease. There were no severe COVID-19 cases in the vaccine group against 6 in the placebo group. Two doses of SOBERANA-02 was 69.7% (95%CI 56.5-78.9) and 74.9% (95%CI 33.7-90.5) efficacious against symptomatic and severe COVID-19, respectively. The occurrence of serious and severe adverse events (AE) was very rare and equally distributed between placebo and vaccine groups. Solicited AEs were slightly more frequent in the vaccine group but predominantly local and mostly mild and transient. Our results indicate that the straightforward to manufacture SOBERANA vaccines are efficacious in a context of Beta and Delta VOC circulation, have a favourable safety profile, and may represent an attractive option for use in COVID-19 vaccination programmes. This study received funds from the National Fund for Science and Technology (FONCI-CITMA-Cuba, contract 2020-20) of the Ministry of Science, Technology and Environment of Cuba.

14 July 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
HYHaiyang Yu
Haiyang Yu
AGAlberto Hernández González
Alberto Hernández González
GTGonzalo Estévez Torres
Gonzalo Estévez Torres
MMMaría Karla González Molina
María Karla González Molina
MCMarcia Hart Casares
Marcia Hart Casares
DPDianelys Quiñones Pérez
Dianelys Quiñones Pérez
(1) Background: The spread of carbapenem-resistant Enterobacterales in hospitals constitutes an important epidemiological and therapeutic problem that especially affects vulnerable patients such as perioperative patients. (2) Methods: We conducted a descriptive, observational, retrospective case-control study of patients infected with carbapenemase-producing carbapenem-resistant Enterobacterales (CP-CRE) and carbapenem-susceptible Enterobacterales during the perioperative period in a tertiary hospital. (3) Results: Metallo-β-lactamase was detected in all 124 CRE isolates, with NDM-type carbapenemase being dominant, while 3 isolates coproduced KPC-type enzyme and showed high resistance rates against all antibiotics except colistin (25.2%). By analyzing the risk factors for infection, steroid use (OR: 3.22, p < 0.01), prior use of two or more antibiotics (OR: 4.04, p = 0.01), prior use of broad-spectrum cephalosporins (OR: 2.40, p = 0.04), and prior use of carbapenem (OR: 4.77, p = 0.03) were found to be independent risk factors for CP-CRE infection. In addition, in this study, we observed that the clinical outcomes of bloodstream infections and pneumonia associated with CP-CRE posed higher mortality risks. However, by analyzing the associations between treatment options and mortality, it was found that, in bloodstream infections caused by CP-CRE, colistin-based regimens showed a significant advantage (PR = 0.40, p = 0.03). (4) Conclusions: High mortality is associated with nosocomial infections in the perioperative period caused by carbapenemase-producing Enterobacterales, the dissemination of which in health care settings in Cuba remains a public health challenge.

Verified
Journal Article
Open access
PDF file
WRWaldemar Baldoquín Rodríguez
Waldemar Baldoquín Rodríguez
MMMayelin Mirabal
Mayelin Mirabal
PSPatrick Van Der Stuyft
Patrick Van Der Stuyft
TPTania Gómez Padrón
Tania Gómez Padrón
VFViviana Fonseca
Viviana Fonseca
VVVeerle Vanlerberghe
Veerle Vanlerberghe
To better guide dengue prevention and control efforts, the use of routinely collected data to develop risk maps is proposed. For this purpose, dengue experts identified indicators representative of entomological, epidemiological and demographic risks, hereafter called components, by using surveillance data aggregated at the level of Consejos Populares (CPs) in two municipalities of Cuba (Santiago de Cuba and Cienfuegos) in the period of 2010–2015. Two vulnerability models (one with equally weighted components and one with data-derived weights using Principal Component Analysis), and three incidence-based risk models were built to construct risk maps. The correlation between the two vulnerability models was high (tau > 0.89). The single-component and multicomponent incidence-based models were also highly correlated (tau ≥ 0.9). However, the agreement between the vulnerability- and the incidence-based risk maps was below 0.6 in the setting with a prolonged history of dengue transmission. This may suggest that an incidence-based approach does not fully reflect the complexity of vulnerability for future transmission. The small difference between single- and multicomponent incidence maps indicates that in a setting with a narrow availability of data, simpler models can be used. Nevertheless, the generalized linear mixed multicomponent model provides information of covariate-adjusted and spatially smoothed relative risks of disease transmission, which can be important for the prospective evaluation of an intervention strategy. In conclusion, caution is needed when interpreting risk maps, as the results vary depending on the importance given to the components involved in disease transmission. The multicomponent vulnerability mapping needs to be prospectively validated based on an intervention trial targeting high-risk areas.

11 April 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
ADAmilcar Duquesne
Amilcar Duquesne
RFRosabel Falcón
Rosabel Falcón
BGBelkys Galindo
Belkys Galindo
OFOnelkis Feliciano
Onelkis Feliciano
OGOderay Gutiérrez
Oderay Gutiérrez
LSLuis Sarmiento
Luis Sarmiento
Evidence of the effectiveness of the tests used to diagnose Helicobacter pylori (H. pylori) in primary healthcare is limited. This cross-sectional study aims to assess the accuracy of tests used for to diagnose H. pylori infection in primary care patients and its relationship with gastroduodenal pathologies. Over 12 months, 173 primary care patients with dyspeptic symptoms were referred for upper gastrointestinal endoscopy to obtain gastric biopsies, and venous blood was extracted from them. H. pylori infection was detected using a rapid urease test (RUT), real-time polymerase chain reaction (RT-PCR), H. pylori-IgG ELISA, and Western blot (WB). The culture and histological findings were used as the reference standard for H. pylori infection. H. pylori prevalence was 50%. There were no significant differences between men and women overall or by age group. The presence of H. pylori was associated with chronic moderate gastritis and its absence with chronic inactive gastritis, as well as the combination of gastritis and gastric lesions (p < 0.05). RUT and ELISA H. pylori -IgG tests showed the highest overall performance (accuracy 98.9% and 84.4%), followed by WB and RT-PCR (accuracy 79.3% and 73.9%). These findings support the notion that combined invasive and noninvasive methods, such as RUT and H. pylori-IgG ELISA, can be a primary diagnostic screening tool for detecting H. pylori among adult dyspeptic patients in Cuba’s primary care setting.

31 December 2022 in Acta Medica Costarricense
Verified
Journal Article
Open access
PDF file
PSPablo Carlos Sariol-Resik
Pablo Carlos Sariol-Resik
TPTatiana Prieto-Domínguez
Tatiana Prieto-Domínguez
MBMiguel Angel Blanco-Aspiazu
Miguel Angel Blanco-Aspiazu
SRSonia Resik-Aguirre
Sonia Resik-Aguirre
WRWaldemar Baldoquín Rodríguez
Waldemar Baldoquín Rodríguez
Objetivo: Determinar las principales causas de muerte y los factores asociados en los pacientes infectados con el VIH ingresados en el hospital del Instituto de Medicina Tropical “Pedro Kourí” durante los años 2017-2018. Métodos: Se realizó un estudio retrospectivo de casos y controles para determinar las causas de la muerte y algunos factores asociados a ella, en el hospital del Instituto de Medicina Tropical “Pedro Kourí”, en el período 2017-2018. Para determinar estos factores se utilizó un análisis multivariado basado en un modelo de regresión logística binaria. Resultados: Las causas de muerte más frecuentes fueron las asociadas al SIDA, fundamentalmente las infecciones oportunistas del sistema respiratorio (41,4%), seguidas por las neoplasias no asociadas al SIDA (25,1%). Los factores que mayor influencia tuvieron sobre la mortalidad fueron la presencia de enfermedad oportunista (OR 14,07 p<0,001) y de neoplasias no asociadas al SIDA (OR 6,76 p=0,005), la alteración de las funciones renal (3,54 p=0,019) y hepática (OR 2,90 p=0,054) y tener mayor carga viral (OR 1,50 p=0,001) y menos tiempo de diagnóstico al momento del ingreso (OR 0,793 p<0,001). El modelo matemático resultante del análisis permitió identificar los principales factores asociados a la mortalidad y explicar su relación con la misma. Conclusiones: Las enfermedades asociadas al SIDA, principalmente las infecciones oportunistas del sistema respiratorio, seguidas por las neoplasias no asociadas al SIDA fueron las causas predominantes de muerte en los pacientes infectados con el VIH que fallecieron en el Instituto de Medicina Tropical “Pedro Kourí” durante el período de estudio. La presencia de neoplasias no asociadas al SIDA, de enfermedades oportunistas, de alteraciones de las funciones renal y hepática, el aumento de la carga viral y el tener menos años de diagnóstico al momento del ingreso, fueron los factores que más contribuyeron a la mortalidad en los pacientes ingresados e infectados con el VIH. El modelo matemático resultante se ajustó bien a los datos y explicó de manera consistente los factores asociados a la mortalidad.